|
VGX Pharmaceuticals
VGX Pharmaceuticals is a DNA vaccine development company with product candidates for the treatment of infectious diseases, cancer, and inflammatory diseases. The Company's clinical development programs include PENNVAX™ for HIV infection and VGX-3100, a DNA therapeutic vaccine for cervical cancer delivered by CELLECTRA ® electroporation device.
Inovio
Inovio Biomedical is developing DNA vaccines using electroporation. Initial human data has shown that Inovio's electroporation-based DNA delivery technology can significantly increase gene expression and immune responses from DNA vaccines. Partners include Merck, Wyeth, Vical, Tripep, University of Southampton, the U.S. Army, NCI, and IAVI. Inovio's technology is protected by an extensive IP covering in vivo electroporation. www.inovio.com
|
|
Cyto Pulse Sciences
Cyto Pulse Sciences was founded in 1996, with the objective of developing and commercializing computer controlled electric field based technology to produce and deliver new medicine therapeutics (polynucleotides) for:
- Cancer treatments (immunotherapy)
- Protection against infectious diseases (prophylaxis therapy)
- Correcting a genetic defect (gene therapy)
Althea Technologies, Inc,
Althea's, services include cGMP contract manufacturing and biologics production. Althea also offers master and working cell banking, protein production, DNA-based vaccines, process development, protein modification, and complex formulations. Our expertise in parenteral processes includes vial/syringe filling under aseptic conditions, lyophilization, stability testing, and final product release.
AltheaDx
AltheaDx is bringing cancer diagnostics into clinical use. Our proprietary gene expression profiles include assays for differential diagnosis of pediatric cancers and for improved diagnosis and management of prostate cancer. We have a track record of reducing the time, risk, and cost of drug development by providing oncology and biopharma testing services. For additional information, please visit www.altheadx.com.
VGXI, Inc.
VGXI, Inc. is a leading contract manufacturer of DNA plasmids. The company’s extensive development, cGMP production, and fill/finish services have passed rigorous reviews by several international regulatory agencies. VGXI offers flexibility, experience, reliability and value to a select group of industry leading clients. Contact us today and see how we can advance your programs.
|
|
VIRxSYS
VIRxSYS is a private biotechnology company with a novel lentiviral vector platform technology for the treatment of HIV/AIDS. VRX1023 is a developing vaccine to provide long-term immune protection against HIV replication, preventing the massive destruction of CD4 T cells and halting the destruction of the immune system by HIV. www.virxsys.com .
Profectus BioSciences
Profectus BioSciences, Inc is a disease focused research and development company dedicated to the prevention and treatment of viral diseases and cancers through the delivery of innovative vaccines and immunotherapies that are based on our proprietary prime/boost vaccination strategies and novel small molecules. www.profectusbiosciences.com .
|
|
BIA Separations
BIA Separations develops and produces CIM® (Convective Interaction Media) Monolithic Columns. These columns are designed for large biomolecule purification, process development, and production. CIM® supports have the advantages of high volumetric throughput, low pressure, low shear, high capacity, and excellent resolution. CIM® Monolithic Columns are friendly to users and their molecules.
Vandalia Research
Vandalia Research provides custom large-scale DNA production with a new technology that enables the mass production of specific, high-quality DNA sequences in a thermo-chemical reaction that replicates DNA outside of a cell. Vandalia is now providing milligram and gram quantities of DNA for a variety of applications, including DNA vaccines. www.vandaliaresearch.com
Aldevron
Aldevron has completed over 20,000 plasmid projects for many applications including DNA-mediated immunization. We can provide DNA for research, clinical and commercial use. Our Genetic Immunization and Antibody (GIA) service can be used to efficiently test DNA vaccines with the latest gene-delivery technology like electroporation. For more information, please visit http://www.aldevron.com .
Fort Dodge Animal Health
Fort Dodge Animal Health is a leading manufacturer and distributor of animal health products worldwide. As a committed partner to veterinarians, Fort Dodge is making a difference in the future of animal health through innovative research and product development that address current and emerging animal health needs.
|
